Formula Feeding and the Gut Microbiome: Closing the Gap

Jarvinen-Seppo addresses what happens to microbial diversity and bifidobacteria colonization when infants are formula-fed or mixed-fed. She explains that formula does not provide human milk oligosaccharides (HMOs), which leaves less available fuel for infant-type bifidobacteria to thrive. Because she considers bifidobacteria colonization important, she notes that exclusive formula feeding can represent a disadvantage relative to breastfeeding.

Mixed feeding, however, can help close part of that gap, since infants still receive some breast milk and its HMOs alongside formula. Jarvinen-Seppo also points to a newer development: some infant formulas on the market are now supplemented with specific HMOs, designed to mimic, to some degree, what breast milk naturally provides. She is careful to note the limits of this approach — formula cannot be supplemented with the full range of beneficial components in breast milk, including the variety of antibodies breast milk contains, so even HMO-supplemented formula only partially closes the gap. Still, she frames these formulas as a meaningful step toward providing more of the right nutritional inputs for infant gut microbiome development when breastfeeding isn't fully possible.

In the next episode, "Gut Microbiome, Immune Programming, and Allergic Disease Risk," Jarvinen-Seppo connects the gut microbiome to allergic disease risk directly, sharing her own research on breast milk antibodies and food allergy protection.